These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
745 related articles for article (PubMed ID: 24588706)
1. Basic biology of adeno-associated virus (AAV) vectors used in gene therapy. Balakrishnan B; Jayandharan GR Curr Gene Ther; 2014; 14(2):86-100. PubMed ID: 24588706 [TBL] [Abstract][Full Text] [Related]
2. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Grimm D; Kay MA Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018 [TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vector as a platform for gene therapy delivery. Wang D; Tai PWL; Gao G Nat Rev Drug Discov; 2019 May; 18(5):358-378. PubMed ID: 30710128 [TBL] [Abstract][Full Text] [Related]
5. Parvovirus-mediated gene transfer for the haemophilias. Walsh CE; Chao H Haemophilia; 2002 Mar; 8 Suppl 2():60-7. PubMed ID: 11966856 [TBL] [Abstract][Full Text] [Related]
6. AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer. Costa Verdera H; Kuranda K; Mingozzi F Mol Ther; 2020 Mar; 28(3):723-746. PubMed ID: 31972133 [TBL] [Abstract][Full Text] [Related]
7. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution. Grimm D; Büning H Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125 [TBL] [Abstract][Full Text] [Related]
8. Cancer gene therapy using adeno-associated virus vectors. Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740 [TBL] [Abstract][Full Text] [Related]
9. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications. Schön C; Biel M; Michalakis S Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882 [TBL] [Abstract][Full Text] [Related]
10. Journey to the Center of the Cell: Tracing the Path of AAV Transduction. Dhungel BP; Bailey CG; Rasko JEJ Trends Mol Med; 2021 Feb; 27(2):172-184. PubMed ID: 33071047 [TBL] [Abstract][Full Text] [Related]
14. High-Throughput Dissection of AAV-Host Interactions: The Fast and the Curious. Herrmann AK; Grimm D J Mol Biol; 2018 Aug; 430(17):2626-2640. PubMed ID: 29782834 [TBL] [Abstract][Full Text] [Related]
15. The state of the art of adeno-associated virus-based vectors in gene therapy. Coura Rdos S; Nardi NB Virol J; 2007 Oct; 4():99. PubMed ID: 17939872 [TBL] [Abstract][Full Text] [Related]
16. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Shi W; Arnold GS; Bartlett JS Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer. Arjomandnejad M; Dasgupta I; Flotte TR; Keeler AM BioDrugs; 2023 May; 37(3):311-329. PubMed ID: 36862289 [TBL] [Abstract][Full Text] [Related]
19. Current development of adeno-associated viral vectors. Romano G Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103 [TBL] [Abstract][Full Text] [Related]
20. Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy. Wagner HJ; Weber W; Fussenegger M Adv Sci (Weinh); 2021 May; 8(9):2004018. PubMed ID: 33977059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]